Early Cancer Screening
Product Highlights
  • Simple and fast, test completed in 15 minutes

  • Non-invasive

  • Prognostic long-term monitoring of
    recurrence risk

  • Complete bioinformatics

  • Detect risks earlier than existing clinical methods

Labyrinth Workflow

Test Duration: 2-3 Days

  • Informed Consent Form

  •  

  • Collect 5-10 ml of Blood
    or Pleural Effusion, Ascites, Cerebrospinal Fluid

  •  

  • Enrichment and Purification

  •  

  • Pathological Analysis Report

Applicable People
  • Health-conscious people

  • High-risk population for cancer

    Meets any of the following:
    -Those with a family history of cancer
    -Person with bad living habits
    -Chronic disease sufferers
    -Long-term carcinogen exposure

     

  • Population with abnormalities in routine screening

    Meets any of the following:
    -Those with imaging abnormalities
    -Individuals with elevated tumor markers
    -Refuse invasive examinations